Morbid Obesity and Left Ventricular Geometry
2006; Lippincott Williams & Wilkins; Volume: 49; Issue: 1 Linguagem: Inglês
10.1161/01.hyp.0000251714.60547.06
ISSN1524-4563
Autores Tópico(s)Cardiovascular Disease and Adiposity
ResumoHomeHypertensionVol. 49, No. 1Morbid Obesity and Left Ventricular Geometry Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBMorbid Obesity and Left Ventricular Geometry Giovanni de Simone Giovanni de SimoneGiovanni de Simone From the Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy. Originally published27 Nov 2006https://doi.org/10.1161/01.HYP.0000251714.60547.06Hypertension. 2007;49:7–9Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: November 27, 2006: Previous Version 1 Obesity is a condition encompassing a broad range of clinical presentations from a nearly normal status to a life-threatening disease. In the absence of a permeating campaign raising the level of attention to the problem of obesity, many obese individuals see their doctors only for esthetic reasons. A large number of subjects, in fact, seem to live quite well even with moderate or severe obesity. Others, albeit feeling healthy, look for dietary interventions not only to improve their body build but also to increase the level of their self-esteem. Some others, a minority, usually those in class III,1 progressively develop symptoms and clinical signs that raise their level of attention and force them to see doctors.The latter type of obese subjects is usually more motivated and, therefore, tends to be more compliant with physicians' suggestions and indications. There is a proportion of these individuals who are considered to be at higher risk, and when their motivations are strong enough, they are sent to bariatric surgery. When examining those obese subjects, doctors and researchers need to be aware that they represent the tip of the iceberg, far away from the reality of obesity in general and from the real cardiovascular risk attributable to obesity in population. Because of the a priori selection, hypertension, diabetes, joint pain, and whatever comorbidity is limiting quality of life are very frequent in those patients. Their cardiovascular risk is higher than in obese patients without prevalent comorbidities, and, unsurprisingly, they also show high levels of left ventricular (LV) mass partly related to coexisting abnormalities consistent with findings in the setting of the metabolic syndrome.2,3 Abnormalities of LV geometry get worse as the severity of morbid obesity increases.In this issue of the journal, Avelar et al4 add another important observation by focusing their study on the effect of obstructive sleep apnea–hypopnea on levels of LV mass in obese patients with some compelling indications for bariatric surgery. The vast majority of these patients were women. Although the authors used a method of normalization of LV mass that minimizes the gender difference, there is, however, gender difference in the distribution of obstructive sleep apnea–hypopnea episodes and, most likely, in their severity, as also confirmed in recent works.5,6 Although the effort of breathing is not necessarily different in men and women when lying the same, the physiology of breathing is different in men and women even in the presence of similar obstructive conditions, particularly when excessive abdominal fat compresses the diaphragm toward the chest.Even considering the potential gender-related limitations, the observation by Avelar et al4 that the degree of sustained nocturnal hypoxemia, rather than the number of apneic and hypopneic episodes, contributes to the variance of LV mass index is interesting, because it indicates a real measurable biological characteristic potentially associated with LV mass. Focusing on hypoxemia overcomes, at least in part, doubts that might be raised by the use of the apnea–hypopnea index as a raw measure of this sleep disturbance. The apnea–hypopnea index is the number of nocturnal apnea or hypopnea episodes normalized by the number of hours of sleep, but its accuracy is substantially limited by the difficulty to standardize a measure of hypopnea because of both technical problems related to measurements of air flow through the respiratory airway during sleep and significant differences between men and women.7 In contrast with the raw indication provided by apnea–hypopnea index, the evaluation of sustained hypoxemia focuses on potential pathophysiologic mechanisms related to the effect of sleep disorders on the cardiovascular system. As the oxygen saturation in the blood decreases and thoracic pressure changes because of obstruction, a number of autonomic, humoral, neurohormonal, and hemodynamic changes take place, which affect the cardiovascular system even during the day.8 Most changes might go back to normality once obstructive sleep apnea is treated and improved.9,10 Sympathetic stimulation because of sustained hypoxemia is particularly insidious,11 and although not directly measured, it is likely present also in the population sample of Avelar et al4 as is suggested by the higher heart rate. Sympathetic hypertone can worsen insulin resistance and can modulate leptin expression in a way that facilitates the development of a vicious cycle, worsens obesity, and promotes the related comorbidities.8Other well-studied mechanisms related to obstructive sleep apnea–hypopnea involve endothelial dysfunction and hypoxia- related expression of proinflammatory cytokines.12–14 A combination of inflammation and vasoconstrictive stimuli largely accounts for the high blood pressure in these patients and for the difficulty to optimally control their values.15 In the morbid obese population in the study by Avelar et al,4 body mass index and nocturnal saturation of O2 account for most of the explained variance of LV mass in addition to systolic blood pressure measured at the office visit. The relatively poor effect of office systolic blood pressure on the variance of LV mass is not different from what has been reported previously in many studies, also in the absence of antihypertensive therapy,16 but in this case, it might be further disturbed by the ongoing antihypertensive therapy. Values of blood pressure taken at the office visit might not reflect the real blood pressure load imposed on the left ventricle during the day.17 A good control of office blood pressure in hypertensive subjects does not mean a good control of blood pressure throughout the day.In particular, a normal or high-normal blood pressure measured at the office visit might underestimate the 24- hour blood pressure load in obese subjects, especially when comorbidities are present. The obesity-associated insulin-resistance blunts the activity of insulin in promoting arterial compliance, which results in increased arterial stiffness18 and consequent increases in central blood pressure. Masked hypertension is found more frequently in patients with central obesity,19 and the lack of nocturnal decrease of blood pressure (nondipping pattern) is frequently associated with central obesity.20 Because central fat distribution is near constant in class II and III obesity, there are many indications that central blood pressure and/or 24-hour blood pressure load could be altered in the population sample of the study by Avelar et al4; also, body mass index and hypoxemia were efficient bioassays of a hemodynamic pattern more complex than that emerging from the simple office blood pressure measurement. It might also be speculated that abdominal obesity and not excess of body fat by itself plays a major role in these findings.In the obese population of the study by Avelar et al,4 the presence of a masked high 24-hour blood pressure overload might, in part, explain the high prevalence of concentric LV geometry. The proportion of subjects with concentric LV geometry is, in fact, substantially higher than would be expected by the general assumption that obesity is associated with a predominant volume overload. An unexpected high prevalence of concentric LV geometry in obesity has already been reported in the current literature,21,22 a finding that is often undervalued or even neglected. The proportion of concentric LV geometry could also be higher in the population sample of Avelar et al,4 because of the relatively young average age. We have shown previously that the relationship between wall thickness and LV cavity dimension increases with increasing age,23 and in the study by Avelar et al,4 the partition values used to classify concentric LV geometry were high and, therefore, more fitting with an older population.There are many reasons to explain the prevalence of concentric LV geometry in morbid obesity. In addition to the possibility of high blood pressure load, direct neurohormonal activation (including sympathetic overactivity, increased expression of endothelin and reduced production of nitroxide activated by hypoxemia,8 and increased in blood viscosity)24,25 might contribute to hemodynamic and local conditions26 yielding concentric LV remodeling. Reverting the construction stimulated by the Avelar et al4 study, these considerations also open the possibility that the phenotypic presentation of a young obese subject with high-normal office blood pressure and concentric LV geometry might carry a high probability of obstructive sleep apnea–hypopnea syndrome, thus, raising the possibility of identifying subjects eligible for a sleep study. Eventually, focus on accurate analysis of LV geometry in obese subjects might provide more information in the future to refine our ability to stratify cardiovascular risk.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.DisclosuresNone.FootnotesCorrespondence to Giovanni de Simone, Department of Clinical and Experimental Medicine, Federico II University Hospital, v. S. Pansini 5, bld 1, 80131 Naples Italy. E-mail [email protected] References 1 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–the evidence report. National Institutes of Health. Obes Res. 1998; 6: 51S–209S.CrossrefMedlineGoogle Scholar2 de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, Kitzman DW, Hopkins PN, Arnett DK, Devereux RB. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens. 2002; 20: 323–331.CrossrefMedlineGoogle Scholar3 Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, Resnick HE, Lee ET, Best LG, de Simone G Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome the Strong Heart Study. Am J Cardiol. 2004; 9340–44.Google Scholar4 Avelar E, Cloward TV, Walker JM, Farney RJ, Strong M, Pendleton RC, Segerson N, Adams TD, Gress RE, Hunt SC, Litwin SE. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension. 2007; 49: 34–39.LinkGoogle Scholar5 Hedner J, Bengtsson-Bostrom K, Peker Y, Grote L, Rastam L, Lindblad U. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J. 2006; 27: 564–570.CrossrefMedlineGoogle Scholar6 Sanfilippo-Cohn B, Lai S, Zhan G, Fenik P, Pratico D, Mazza E, Veasey SC. Sex differences in susceptibility to oxidative injury and sleepiness from intermittent hypoxia. Sleep. 2006; 29: 152–159.CrossrefMedlineGoogle Scholar7 Edwards N, Wilcox I, Sullivan CE. Sleep apnoea in women. Thorax. 1998; 53: S12–S15.CrossrefMedlineGoogle Scholar8 Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation. 2004; 109: 951–957.LinkGoogle Scholar9 Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest. 2003; 124: 594–601.CrossrefMedlineGoogle Scholar10 Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999; 100: 2332–2335.CrossrefMedlineGoogle Scholar11 Grassi G, Facchini A, Trevano FQ, Dell'Oro R, Arenare F, Tana F, Bolla G, Monzani A, Robuschi M, Mancia G. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005; 46: 321–325.LinkGoogle Scholar12 Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, Vela-Bueno A, Kales A, Chrousos GP. Chronic insomnia is associated with a shift of interleukin (IL)-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism. 2002; 51: 887–892.CrossrefMedlineGoogle Scholar13 Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003; 290: 1906– 1914.CrossrefMedlineGoogle Scholar14 Tam CS, Wong M, McBain R, Bailey S, Waters KA. Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health. 2006; 42: 277–282.CrossrefMedlineGoogle Scholar15 Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax. 2000; 55: 736–740.CrossrefMedlineGoogle Scholar16 Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, Spitzer MC, Laragh JH. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 1990; 81: 25–36.CrossrefMedlineGoogle Scholar17 Tsioufis C, Stefanadis C, Goumas G, Pitsavos C, Toutouzas P. Relation of ambulatory blood pressure load with left ventricular geometry in untreated patients with mild-to-moderate hypertension. J Hum Hypertens. 1999; 13: 677–682.CrossrefMedlineGoogle Scholar18 Westerbacka J, Vehkavaara S, Bergholm R, Wilkinson I, Cockcroft J, Yki-Jarvinen H. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity. Diabetes. 1999; 48: 821–827.CrossrefMedlineGoogle Scholar19 Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002; 40: 795–796.LinkGoogle Scholar20 Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 2005; 45: 602–607.LinkGoogle Scholar21 de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994; 23: 600–606.LinkGoogle Scholar22 Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel F. Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes Res. 2002; 10: 489–498.CrossrefMedlineGoogle Scholar23 de Simone G, Daniels SR, Kimball TR, Roman MJ, Romano C, Chinali M, Galderisi M, Devereux RB. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation. Hypertension. 2005; 45: 64–68.LinkGoogle Scholar24 Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, Mishima M, Kuno K. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996; 153: 1972–1976.CrossrefMedlineGoogle Scholar25 Dikmenoglu N, Ciftci B, Ileri E, Guven SF, Seringec N, Aksoy Y, Ercil D. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med. 2006; 7: 255–261.CrossrefMedlineGoogle Scholar26 Brilla CG, Maisch B, Weber KT Myocardial collagen matrix remodelling in arterial hypertension. Eur Heart J. 1992; 13 (suppl D): 24–32.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Luca A, Curpan A, Braha E, Ţarcă E, Iordache A, Luca F and Adumitrachioaiei H (2022) Increasing Trends in Obesity-Related Cardiovascular Risk Factors in Romanian Children and Adolescents—Retrospective Study, Healthcare, 10.3390/healthcare10122452, 10:12, (2452) Berezin A and Berezin A (2020) Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review, Diabetes Therapy, 10.1007/s13300-020-00835-9, 11:6, (1271-1291), Online publication date: 1-Jun-2020. Listopad O, Bazhenova E, Ionin V, Belyaeva O and Baranova E (2015) Apelin and heart remodeling in patients with abdominal obesity, The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University, 10.24884/1607-4181-2015-22-2-17-19, 22:2, (17-19) Santos M and Shah A (2014) Alterations in Cardiac Structure and Function in Hypertension, Current Hypertension Reports, 10.1007/s11906-014-0428-x, 16:5, Online publication date: 1-May-2014. Cuspidi C, Rescaldani M, Sala C and Grassi G (2014) Left-ventricular hypertrophy and obesity, Journal of Hypertension, 10.1097/HJH.0b013e328364fb58, 32:1, (16-25), Online publication date: 1-Jan-2014. Aurigemma G, de Simone G and Fitzgibbons T (2013) Cardiac Remodeling in Obesity, Circulation: Cardiovascular Imaging, 6:1, (142-152), Online publication date: 1-Jan-2013. Damiano S, De Marco M, del Genio F, Contaldo F, Gerdts E, de Simone G and Pasanisi F (2012) Effect of bariatric surgery on left ventricular geometry and function in severe obesity, Obesity Research & Clinical Practice, 10.1016/j.orcp.2012.02.008, 6:3, (e189-e196), Online publication date: 1-Jul-2012. de Simone G, Devereux R and de Divitiis O (2011) Cardiovascular Damage in Obesity and Metabolic Syndrome Nutritional and Metabolic Bases of Cardiovascular Disease, 10.1002/9781444318456.ch7, (49-55) Sweeney G, Litwin S and Abel E (2011) Obesity and Cardiac Dysfunction Metabolic Basis of Obesity, 10.1007/978-1-4419-1607-5_14, (257-292), . Greenberg B and Cleland J (2010) Emerging Therapies for Heart Failure Management of Heart Failure, 10.1002/9780470669402.ch7, (157-175) Greenberg B and Barnard D (2010) Preventing Heart Failure Management of Heart Failure, 10.1002/9780470669402.ch1, (1-26) Payne R, Wilkinson I and Webb D (2009) Arterial Stiffness and Hypertension, Hypertension, 55:1, (9-14), Online publication date: 1-Jan-2010. Mascareno E, Beckles D, Dhar-Mascareno M and Siddiqui M (2009) Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide, Vascular Pharmacology, 10.1016/j.vph.2009.06.005, 51:2-3, (198-204), Online publication date: 1-Aug-2009. Abel E, Litwin S and Sweeney G (2008) Cardiac Remodeling in Obesity, Physiological Reviews, 10.1152/physrev.00017.2007, 88:2, (389-419), Online publication date: 1-Apr-2008. Owan T and Litwin S (2007) Is there a cardiomyopathy of obesity?, Current Heart Failure Reports, 10.1007/s11897-007-0016-3, 4:4, (221-228), Online publication date: 1-Dec-2007. Gavish B, Ben-Dov I and Bursztyn M (2007) Ambulatory Arterial Stiffness Index Is Not a Specific Marker of Reduced Arterial Compliance, Hypertension, 50:2, (e18-e18), Online publication date: 1-Aug-2007.Cereda E and Malavazos A (2007) A Possible Role of Visceral Fat-Related Inflammation in Linking Obstructive Sleep Apnea to Left Ventricular Hypertrophy, Hypertension, 49:4, (e23-e23), Online publication date: 1-Apr-2007.Li Y, Wang J, Dolan E, O'Brien E, Hansen T, Ibsen H, Kikuya M, Imai Y, Richart T, Thijs L and Staessen J (2007) Letter to the Editor, Hypertension, 49:2, (e8-e9), Online publication date: 1-Feb-2007. January 2007Vol 49, Issue 1 Advertisement Article InformationMetrics https://doi.org/10.1161/01.HYP.0000251714.60547.06PMID: 17130309 Originally publishedNovember 27, 2006 PDF download Advertisement SubjectsCardiomyopathyClinical StudiesDiabetes, Type 2EchocardiographyEpidemiologyHeart FailureObesity
Referência(s)